Technical Analysis for NLAB - Nuoncology Labs Inc

Grade Last Price % Change Price Change
grade B 0.009 0.00% 0.0000
NLAB closed unchanged on Wednesday, August 21, 2019, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Down
See historical NLAB trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Strong but Oversold Other 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Crossed Above 50 DMA Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Strong but Oversold Other 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%

Older signals for NLAB ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
NuOncology Labs, Inc. is a development stage company engaged in the cancer research & clinical testing laboratories industries. In its pharmaceutical research NuOncology Labs engages in research, development, testing and licensing of promising pharmaceuticals and other cancer treatments. In its clinical laboratory business, the Company conducts predictive drug response tests for the optimization of chemotherapeutic cancer treatment of individual cancer patients and provides other contracted clinical testing services. Currently, the Company's subsidiaries, Paracure and IPRLL, have four issued patents and three additional allowed patent applications. Additionally, the subsidiaries have four U.S. and 12 international pending patent applications directed to various chemotherapy compounds and methods of cancer treatment.
Medicine Health Cancer Pharmaceuticals Pharmaceutical Industry Pharmaceutical Industry In China Chemotherapy Cancer Treatment Pharmaceutical Research National Cancer Institute Cancer Research
Is NLAB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.029
52 Week Low 0.001
Average Volume 91,132
200-Day Moving Average 0.0
50-Day Moving Average 0.0081
20-Day Moving Average 0.0133
10-Day Moving Average 0.0123
Average True Range 0.0035
ADX 18.62
+DI 45.8418
-DI 45.6389
Chandelier Exit (Long, 3 ATRs ) 0.0185
Chandelier Exit (Short, 3 ATRs ) 0.0135
Upper Bollinger Band 0.0274
Lower Bollinger Band -0.0008
Percent B (%b) 0.35
BandWidth 212.030075
MACD Line 0.0007
MACD Signal Line 0.0021
MACD Histogram -0.0013
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0090
Resistance 3 (R3) 0.0090 0.0090 0.0090
Resistance 2 (R2) 0.0090 0.0090 0.0090 0.0090
Resistance 1 (R1) 0.0090 0.0090 0.0090 0.0090 0.0090
Pivot Point 0.0090 0.0090 0.0090 0.0090 0.0090
Support 1 (S1) 0.0090 0.0090 0.0090 0.0090 0.0090
Support 2 (S2) 0.0090 0.0090 0.0090 0.0090
Support 3 (S3) 0.0090 0.0090 0.0090
Support 4 (S4) 0.0090